USPTO 2015–2025 USPTO PatentsView US Corporation

Labcyte Inc.

USPTO PatentsView assignee record - 44 granted patents across 17 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

RSS updates for this company

The verdict

According to USPTO PatentsView, Labcyte ranks #7,431 of 49,997 tracked US assignees by granted-patent volume, with 44 patents across 17 technology areas.

#7,431
of 49,997 US assignees by volume
Top 18%
by Innovation Score (47.6/100)
24.3
avg claims per patent
+100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7431 · US Corporation #7,431 · 44 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 44 grants
  • UPPER-Q #7,431/49,997
  • PHOTO-FINISH K-International
  • CPC-FOCUS B01L · 17 areas
  • INNOV-PAR 47.6/100
  • CLAIMS-DENSE 24.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: K-International, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Labcyte’s 47.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Labcyte

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Labcyte's Innovation Score is 47.6/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Labcyte?

Each dot is one of Labcyte’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Labcyte’s own 24.3 claims/patent is ABOVE the 17.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Labcyte vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 43.944.044.04444.044.044.1 51015202530 Granted patents (volume) Avg claims / patent K-International, Inc. - 44, 6.66K-internationalKenwood Limited - 44, 8.2KenwoodKpmg LLP - 44, 18.73Kpmg LLPKulzer GMBH - 44, 17.43KulzerLancium LLC - 44, 22.32LanciumLT Materials Co., Ltd. - 44, 12.48LT MaterialsLeo Pharma A/S - 44, 20.91Leo Pharma A/SLucomm Technologies, Inc. - 44, 25.23LucommLabcyte Inc. - 44, 24.25Labcyte
Labcyte vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Labcyte's grants concentrate

Labcyte Inc. is a focused PatentsView assignee: 17 CPC subclasses with 90.9% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2018 (8 grants) versus a trough of 1 in 2019. By volume, Labcyte sits between K-International, Inc. and Lucomm Technologies, Inc..

Labcyte's three-year grant acceleration

Labcyte Inc. shows 12 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Labcyte's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Labcyte holds 44 patents at rank #7,431, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Labcyte

By rank, the assignees closest to #7,431 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in Labcyte's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Labcyte, neither rank-band nor same-CPC leaders (those blocks stay above). In B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), Labcyte ranks #45 of 1,325 assignees by patent count in that subclass.

Labcyte's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 2015201720182019202020212022202320242025 5
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Labcyte Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 4.5%
2017 2 4.5%
2018 8 18.2%
2019 1 2.3%
2020 8 18.2%
2021 6 13.6%
2022 2 4.5%
2023 5 11.4%
2024 5 11.4%
2025partial year 5 11.4%

Which technologies does Labcyte Inc. patent most?

Top 15 of 17 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Labcyte Inc.'s patent record in context - here's where to go next.

  • Labcyte Inc.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 90.9% of its portfolio - see every assignee active in that class. Explore B01L
  • Ranked #7,431 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Labcyte Inc. against K-International, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 47.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.